Mark Frederiks

Mark Frederiks is a Researcher in the Department of Radiation Oncology at the University of Groningen's Faculty of Medical Sciences. His work focuses on advancing proton radiotherapy techniques and reducing treatment complications in cancer patients, with particular emphasis on esophageal and head and neck cancers.

His primary research interests revolve around Proton Therapy optimization, Esophageal Cancer treatment protocols, and Pneumonia Prevention in cancer therapy. Frederiks investigates how proton radiotherapy can significantly reduce complications like pneumonia compared to conventional radiation methods, especially in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy and resection.

Analysis of his recent publications reveals a strong focus on treatment toxicity reduction and normal tissue complication probability modeling. His work demonstrates how proton therapy can lower pneumonia incidence in esophageal cancer patients by approximately 100% compared to traditional methods, while his research on head and neck cancer focuses on creating comprehensive international models for predicting treatment complications.

Frederiks actively collaborates with international research teams on radiation oncology studies, contributing to global efforts in optimizing cancer treatment protocols and reducing adverse effects for patients undergoing radiotherapy.